v3.26.1
Equity-Accounted Investees and Joint Business - Ownership and carrying amount (Details) - EUR (€)
€ in Millions
12 Months Ended
Jul. 29, 2021
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Equity-Accounted Investees and Joint Business          
Equity-accounted investments   € 97 € 69 € 421 € 1,498
Total equity accounted investees with similar activity to that of the Group          
Equity-Accounted Investees and Joint Business          
Equity-accounted investments     € 69 418 1,494
Grifols Egypt Plasma Derivatives S.A.E.          
Equity-Accounted Investees and Joint Business          
Ownership interest (as a percent) 49.00% 49.00% 49.00%    
Equity-accounted investments   € 76 € 63 46 36
BioDarour P.J.S. Co.          
Equity-Accounted Investees and Joint Business          
Ownership interest (as a percent)   39.40% 34.30%    
Equity-accounted investments   € 2 € 6 € 11 € 5
Grifols Canada Plasma, Inc.          
Equity-Accounted Investees and Joint Business          
Ownership interest (as a percent)   50.10%      
Equity-accounted investments   € 19